HRMY - Harmony Biosciences Holdings, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$46.80
DETAILS
HIGH:
$62.00
LOW:
$31.00
MEDIAN:
$46.00
CONSENSUS:
$46.80
UPSIDE:
55.22%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Revenue | 868.5 | 714.7 | 582.0 | 437.9 | 305.4 | 159.7 | 6.0 | 0 |
| Cost of Revenue | 198.3 | 156.8 | 121.2 | 83.5 | 55.5 | 27.7 | 1.6 | 0.2 |
| Gross Profit | 670.1 | 557.9 | 460.8 | 354.4 | 249.9 | 132.0 | 4.4 | (0.2) |
| Operating Expenses | ||||||||
| R&D Expenses | 189.6 | 145.8 | 76.1 | 70.9 | 30.4 | 19.4 | 69.6 | 12.4 |
| SG&A Expenses | 272.0 | 221.3 | 192.7 | 163.3 | 132.0 | 95.6 | 80.7 | 29.1 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 461.6 | 367.1 | 268.8 | 234.2 | 162.4 | 115.0 | 150.3 | 41.4 |
| Operating Income | ||||||||
| Operating Income | 208.5 | 190.8 | 192.0 | 120.2 | 87.5 | 17.0 | (145.9) | (41.4) |
| Interest Expense | 14.6 | 17.5 | 23.8 | 18.8 | 24.2 | 28.2 | 6.1 | 0 |
| Interest Income | 21.9 | 18.5 | 14.7 | 3.1 | 0.2 | 0 | 0 | 0 |
| Profitability | ||||||||
| EBITDA | 255.0 | 233.4 | 221.5 | 146.9 | 80.5 | 1.5 | (142.7) | (41.3) |
| EBIT | 229.7 | 209.3 | 197.2 | 123.5 | 61.6 | (8.7) | (145.9) | (41.4) |
| Income Before Tax | 215.1 | 191.8 | 173.4 | 104.7 | 37.4 | (36.9) | (152.0) | (39.9) |
| Income Tax Expense | 56.4 | 46.3 | 44.5 | (76.8) | 2.8 | 0 | 0 | 0 |
| Net Income | 158.7 | 145.5 | 128.9 | 181.5 | 34.6 | (36.9) | (152.0) | (39.9) |
| Per Share Data | ||||||||
| EPS (Basic) | 2.76 | 2.56 | 2.17 | 3.07 | 0.60 | -1.12 | -2.94 | -1.42 |
| EPS (Diluted) | 2.71 | 2.51 | 2.13 | 2.97 | 0.58 | -1.10 | -2.94 | -1.42 |
| Shares Outstanding | 57.5 | 56.9 | 59.5 | 59.2 | 57.5 | 56.9 | 63.7 | 49.2 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||
| Cash & Cash Equivalents | 752.5 | 453.0 | 311.7 | 243.8 | 234.3 | 228.6 | 24.5 | 83.5 |
| Short-Term Investments | 22.8 | 14.2 | 41.8 | 79.3 | 0 | 0 | 0 | 0 |
| Net Receivables | 96.8 | 83.0 | 74.1 | 54.7 | 34.8 | 22.2 | 4.3 | 0 |
| Inventory | 5.4 | 7.2 | 5.4 | 4.3 | 4.4 | 3.8 | 1.1 | 0 |
| Other Current Assets | 13.5 | 8.1 | 5.5 | 8.8 | 3.2 | 1.3 | 0.3 | 2.5 |
| Total Current Assets | 907.0 | 579.3 | 451.1 | 400.3 | 284.4 | 262.9 | 31.5 | 86.7 |
| Non-Current Assets | ||||||||
| Property, Plant & Equipment | 5.3 | 3.4 | 0.4 | 0.6 | 4.1 | 0.9 | 1.3 | 1.6 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 89.4 | 113.3 | 137.1 | 161.0 | 143.9 | 162.3 | 72.2 | 0 |
| Long-Term Investments | 107.4 | 108.9 | 72.2 | 22.6 | 0 | 0 | 0 | 0.5 |
| Other Non-Current Assets | 12.8 | 194.4 | 6.6 | 3.5 | 1.0 | 0.9 | 1.7 | 0.5 |
| Total Non-Current Assets | 364.6 | 419.9 | 360.4 | 273.6 | 149.0 | 164.2 | 75.2 | 2.6 |
| Total Assets | 1,271.6 | 999.2 | 811.4 | 673.9 | 433.4 | 427.1 | 106.7 | 89.3 |
| Current Liabilities | ||||||||
| Account Payables | 17.7 | 13.7 | 17.7 | 3.8 | 1.0 | 2.6 | 6.4 | 1.5 |
| Short-Term Debt | 86.9 | 16.2 | 15 | 2 | 2 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 129.1 | 4.4 | 107.3 | 1.6 | 0.0 | 100.3 | 0.8 | 0.3 |
| Total Current Liabilities | 252.1 | 175.1 | 163.8 | 78.9 | 53.8 | 134.5 | 19.9 | 7.2 |
| Non-Current Liabilities | ||||||||
| Long-Term Debt | 148.2 | 163.0 | 178.6 | 189.6 | 190.0 | 194.2 | 97.9 | 324.2 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (324.5) |
| Other Non-Current Liabilities | (3.4) | 1.1 | 2.1 | 2.5 | 0.8 | 1.1 | 0.5 | (323.7) |
| Total Non-Current Liabilities | 149.3 | 165.0 | 180.7 | 192.1 | 193.2 | 195.4 | 98.4 | 0.5 |
| Total Liabilities | 401.4 | 340.0 | 344.5 | 271.0 | 246.9 | 329.9 | 118.3 | 7.8 |
| Stockholders' Equity | ||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0.0 |
| Retained Earnings | 160.9 | 2.2 | (143.3) | (272.1) | (453.6) | (488.2) | (422.9) | (242.7) |
| Accumulated Other Comprehensive Income | 0.3 | 0.1 | 0.0 | (0.2) | 0 | 0 | 0 | (0.0) |
| Total Stockholders' Equity | 870.2 | 659.2 | 467.0 | 402.8 | 186.5 | 97.2 | (11.6) | 81.5 |
| Total Liabilities & Equity | 1,271.6 | 999.2 | 811.4 | 673.9 | 433.4 | 427.1 | 106.7 | 89.3 |
| Debt Metrics | ||||||||
| Total Debt | 239.6 | 181.4 | 193.6 | 191.6 | 195.7 | 194.2 | 97.9 | 324.2 |
| Net Debt | (512.9) | (271.6) | (118.1) | (52.1) | (38.6) | (34.4) | 73.5 | 240.7 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | 158.7 | 145.5 | 128.9 | 181.5 | 34.6 | (36.9) | (152.0) | (39.9) |
| Depreciation & Amortization | 25.3 | 24.1 | 24.4 | 25.0 | 21.1 | 10.2 | 3.8 | 0.2 |
| Stock-Based Compensation | 44.9 | 42.6 | 31.7 | 26.9 | 16.1 | 4.7 | 9.9 | 1.1 |
| Change in Working Capital | 91.8 | (7.3) | 35.0 | (6.9) | 2.2 | (11.6) | 3.4 | (0.2) |
| Other Non-Cash Items | 27.5 | 44.2 | 12.9 | (82.1) | 24.6 | 4.9 | 59.4 | 2.1 |
| Operating Cash Flow | 348.2 | 219.8 | 219.4 | 144.5 | 98.6 | (3.0) | (75.4) | (38.8) |
| Investing Activities | ||||||||
| Capital Expenditure | (0.3) | (1.2) | (0.3) | (0.2) | (0.3) | (2.0) | (0.1) | (1.3) |
| Acquisitions | 0 | (33.1) | (37.0) | 0 | 0 | (2) | 0 | 0 |
| Purchases of Investments | (86.2) | (105.3) | (127.5) | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 81.1 | 98.5 | 118.3 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (15) | (26.5) | 0 | (141.7) | (100) | 2 | (127) | 0 |
| Investing Cash Flow | (39.6) | (67.5) | (46.4) | (141.8) | (100.3) | (2.0) | (127.1) | (1.3) |
| Financing Activities | ||||||||
| Net Debt Issuance | (16.2) | (15) | (1.2) | (2) | (0.5) | 79.4 | 100 | 0 |
| Stock Repurchased | 0 | 0 | (100) | 0 | 0 | (0.2) | 0 | (3.2) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (3.0) | (2.5) | (3.8) | 8.8 | 7.9 | 129.9 | 43.8 | (0.2) |
| Financing Cash Flow | (9.0) | (11.0) | (105.6) | 6.8 | 7.4 | 209.2 | 143.8 | 21.6 |
| Cash Position | ||||||||
| Net Change in Cash | 299.5 | 141.3 | 67.4 | 9.5 | 5.7 | 204.2 | (58.8) | (18.5) |
| Cash at Beginning | 453.0 | 311.9 | 244.5 | 235.1 | 229.4 | 25.2 | 84.0 | 102.5 |
| Cash at End | 752.5 | 453.3 | 311.9 | 244.5 | 235.1 | 229.4 | 25.2 | 84.0 |
| Free Cash Flow | 347.9 | 218.7 | 219.1 | 144.3 | 98.3 | (5.0) | (75.6) | (40.1) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 868.5 | 714.7 | 582.0 | 437.9 | 305.4 | 159.7 | 6.0 | 0 |
| Gross Profit | 670.1 | 557.9 | 460.8 | 354.4 | 249.9 | 132.0 | 4.4 | (0.2) |
| Operating Income | 208.5 | 190.8 | 192.0 | 120.2 | 87.5 | 17.0 | (145.9) | (41.4) |
| Net Income | 158.7 | 145.5 | 128.9 | 181.5 | 34.6 | (36.9) | (152.0) | (39.9) |
| EPS (Diluted) | 2.71 | 2.51 | 2.13 | 2.97 | 0.58 | -1.10 | -2.94 | -1.42 |
| Balance Sheet | ||||||||
| Cash & Equivalents | 752.5 | 453.0 | 311.7 | 243.8 | 234.3 | 228.6 | 24.5 | 83.5 |
| Total Assets | 1,271.6 | 999.2 | 811.4 | 673.9 | 433.4 | 427.1 | 106.7 | 89.3 |
| Total Debt | 239.6 | 181.4 | 193.6 | 191.6 | 195.7 | 194.2 | 97.9 | 324.2 |
| Stockholders' Equity | 870.2 | 659.2 | 467.0 | 402.8 | 186.5 | 97.2 | (11.6) | 81.5 |
| Cash Flow | ||||||||
| Operating Cash Flow | 348.2 | 219.8 | 219.4 | 144.5 | 98.6 | (3.0) | (75.4) | (38.8) |
| Capital Expenditure | (0.3) | (1.2) | (0.3) | (0.2) | (0.3) | (2.0) | (0.1) | (1.3) |
| Free Cash Flow | 347.9 | 218.7 | 219.1 | 144.3 | 98.3 | (5.0) | (75.6) | (40.1) |